Understanding sperm development, testosterone, metabolic health, paternal age, environmental exposures, reproductive genetics, and the emerging science of how a father's health before conception may influence offspring development.
When a couple decides to have a child, whose health becomes the focus of preconception planning?
Traditionally, the answer has been the woman.
Preconception counseling often emphasizes menstrual health, reproductive hormones, ovulation, prenatal vitamins, nutrition, and the maternal environment.
These subjects are critically important.
But what about the prospective father?
Could his metabolic health influence fertility?
Can medications, smoking, alcohol, or anabolic steroids affect sperm production?
Does paternal age influence reproductive risk?
Can the biological conditions in which sperm develop affect the resulting embryo?
And if a man's health before conception matters, why is comprehensive male preconception care so rarely discussed?
In 2008, Frey and colleagues published The Clinical Content of Preconception Care: Preconception Care for Men in the American Journal of Obstetrics & Gynecology.
The authors argued that male reproductive health had been overlooked within conventional preconception healthcare.
They identified several reasons why this needed to change.
Men contribute biologically to conception, influence reproductive and family-planning decisions, can affect their partners' health, and play important roles in preparing for parenthood.
Most importantly, preconception care creates an opportunity to improve men's own lifelong health.
Nearly two decades later, research published in JAMA, The New England Journal of Medicine, and Nature Portfolio journals has strengthened the rationale for including men in reproductive healthcare.
Studies have identified associations between metabolic health and semen quality, clarified the effects of certain medications on sperm production, challenged popular fertility supplementation strategies, and investigated how paternal exposures may influence offspring biology.
The scientific picture remains complex.
Not every association establishes causation, and many proposed mechanisms of paternal influence on offspring are still being investigated.
Nevertheless, the evidence supports a fundamental shift in how we approach conception.
Preparing for pregnancy should not be treated exclusively as a maternal responsibility. Male health deserves independent attention, both for the prospective father's well-being and its potential relevance to reproduction.
1. Men's Preconception Health: More Than Fertility Testing
Preconception care refers to preventive healthcare intended to identify and address factors that may influence conception, pregnancy, and future health.
For men, this involves more than determining whether sperm are present.
A comprehensive approach may consider reproductive history, medical conditions, medications, lifestyle behaviors, environmental exposures, mental health, and family-planning goals.
The original AJOG paper described six reasons for including men in preconception care: supporting intentional family planning, improving biological reproductive health, reducing risks to partners, encouraging supportive relationship behaviors, preparing for fatherhood, and promoting men's general health.
These remain useful organizing principles.
A man's health matters independently of whether he wishes to become a father.
However, the preconception period may create an additional reason to address overlooked medical concerns.
For example, erectile dysfunction may be an early indication of vascular or metabolic disease.
Reduced fertility may be associated with endocrine or anatomical conditions requiring evaluation.
And unhealthy lifestyle behaviors may influence both reproductive and long-term cardiometabolic health.
Preconception healthcare therefore provides an opportunity to examine the entire person rather than focus exclusively on reproductive outcomes.
2. Understanding Sperm Production
Sperm production, or spermatogenesis, occurs within the seminiferous tubules of the testes.
The process begins with developing germ cells and progresses through several stages of cell division and differentiation.
Mature sperm contain a highly specialized structure designed to deliver paternal genetic material during fertilization.
However, sperm production is not instantaneous.
Human spermatogenesis takes approximately 74 days, followed by additional maturation and transport through the epididymis.
This means that sperm ejaculated today reflect biological processes that began several weeks earlier.
Hormonal regulation is also essential.
The hypothalamus releases gonadotropin-releasing hormone, which influences pituitary secretion of luteinizing hormone and follicle-stimulating hormone.
Luteinizing hormone stimulates Leydig cells to produce testosterone.
Follicle-stimulating hormone interacts with Sertoli cells, which provide important support for developing germ cells.
Adequate intratesticular testosterone concentrations are necessary for normal sperm production.
These relationships explain why endocrine disorders, certain medications, and significant physiological disturbances may interfere with fertility.
They also explain why changes intended to influence sperm production generally require time before their effects can be assessed.
3. What Does a Semen Analysis Actually Measure?
A semen analysis is one of the principal investigations used in evaluating male fertility.
It assesses several characteristics of an ejaculate.
Semen volume measures the amount of fluid produced.
Sperm concentration estimates the number of sperm per milliliter.
Total sperm number considers sperm concentration together with semen volume.
Motility describes the ability of sperm to move.
Progressive motility measures the proportion moving forward.
Morphology evaluates certain structural characteristics.
These measurements help identify possible abnormalities in sperm production, transport, or function.
However, a semen analysis does not directly measure the probability that a particular couple will conceive.
Some men with results below reference limits can achieve pregnancy naturally.
Others with results within reference ranges may experience infertility.
Results also vary between samples.
For this reason, abnormal findings often require repeat testing and further clinical evaluation.
Current American Urological Association and American Society for Reproductive Medicine guidance emphasizes assessing both partners when infertility is present.
A semen analysis is an important clinical tool, but it should be interpreted alongside reproductive history, physical examination, and the broader medical context.
4. Male Infertility Deserves Early Evaluation
Infertility is a couple-level clinical concern, even when a contributing condition is identified in one partner.
Male factors may contribute independently or in combination with female reproductive factors.
A 2025 clinical practice review published in The New England Journal of Medicine, Infertility Evaluation and Treatment, emphasized that reproductive issues in men are common and that effective management is available for selected conditions.
Evaluation may identify varicoceles, hormonal abnormalities, obstruction, genetic conditions, or other causes.
Importantly, a male fertility evaluation should not automatically be postponed until every possible female reproductive investigation has been completed.
When pregnancy has not occurred after 12 months of regular unprotected intercourse, evaluation is generally appropriate.
Earlier evaluation may be indicated when the female partner is 35 or older, when a known reproductive condition exists, or when other clinical factors warrant attention.
A male infertility history may include previous pregnancies, childhood testicular conditions, infections, surgeries, medication use, sexual function, and exposure history.
These details can identify conditions that would otherwise be missed by relying on semen analysis alone.
5. Metabolic Health and Male Fertility
One of the most important developments in reproductive research concerns the relationship between metabolic health and sperm quality.
Obesity can involve changes in insulin sensitivity, adipose tissue function, inflammatory signaling, endocrine regulation, and other physiological processes.
These changes may influence the reproductive system.
For example, adipose tissue participates in the metabolism of sex hormones.
Increased adiposity may be associated with lower circulating testosterone concentrations and altered hormonal feedback.
Insulin resistance and other metabolic abnormalities may also influence reproductive physiology.
However, these relationships are not uniform.
Not every man with obesity experiences infertility.
Not every man with normal BMI has normal reproductive function.
Body mass index is also an imperfect measure of adiposity and metabolic health.
The value of metabolic assessment lies in identifying clinically meaningful conditions rather than treating body weight as the sole determinant of fertility.
6. What Does the Research Say About BMI and Semen Quality?
A 2024 systematic review and meta-analysis published in the International Journal of Obesity, a Nature Portfolio journal, examined associations between BMI and semen quality.
The investigators included 50 studies involving 71,337 men.
Compared with men in the reference BMI category, men with obesity had lower average semen volume, total sperm number, motility, progressive motility, and normal morphology.
For example, obesity was associated with an average reduction of approximately 19.6 million in total sperm number.
The reductions were generally more pronounced in men with higher classes of obesity.
These findings support an association between excess adiposity and poorer average semen quality.
However, the studies were heterogeneous.
Many were observational, meaning the findings do not establish that higher BMI directly caused the measured differences.
Factors such as smoking, chronic disease, medication use, and other lifestyle behaviors may contribute.
Moreover, semen characteristics are intermediate biological measurements.
They do not necessarily translate directly into differences in live-birth rates.
7. BMI, Time to Pregnancy, and Miscarriage Risk
In September 2024, researchers published Preconception and Early-Pregnancy Body Mass Index in Women and Men, Time to Pregnancy, and Risk of Miscarriage in JAMA Network Open.
The study examined participants in a population-based cohort in Rotterdam, the Netherlands.
Researchers evaluated BMI before or during early pregnancy in both prospective parents.
They also investigated time to pregnancy, subfertility, and miscarriage.
BMI outside the normal category was associated with lower fecundability and increased likelihood of selected adverse reproductive outcomes.
The findings are important because they reinforce the relevance of both partners' health.
However, this study was observational.
It does not demonstrate that deliberately changing BMI will necessarily improve conception rates or prevent miscarriage.
Nor should the findings be used to assign responsibility for pregnancy loss to either parent.
Instead, they support including metabolic health within a comprehensive reproductive assessment.
8. Can Weight Loss Improve Sperm Quality?
An important question follows from these associations.
If excess adiposity is associated with reduced semen quality, can improving metabolic health reverse some of these changes?
A 2022 study published in Human Reproduction investigated this question among men with obesity.
The study included 56 men participating in a structured weight-management intervention.
Following an eight-week low-calorie dietary intervention, participants lost an average of approximately 16.5 kilograms.
Sperm concentration increased approximately 1.49-fold, while total sperm count increased approximately 1.41-fold.
Improvements were maintained over the following year among men who maintained their weight loss.
However, other semen measures did not demonstrate equivalent improvements.
The study was relatively small, and it did not establish that weight loss increased live-birth rates.
Furthermore, its intervention was conducted under research conditions and should not be interpreted as a recommendation for all men to follow an extremely low-calorie diet.
The findings nevertheless suggest that some obesity-associated changes in semen quality may be modifiable.
For men with excess adiposity and relevant medical concerns, evidence-based weight management may provide broader health benefits alongside possible reproductive improvements.
9. Testosterone: Why More Is Not Always Better
Testosterone is essential for male reproductive physiology.
However, an important distinction exists between testosterone produced by the testes and testosterone administered externally.
The hypothalamic–pituitary–testicular axis regulates sperm production through feedback mechanisms.
When testosterone is administered from an external source, circulating concentrations may increase.
However, the resulting negative feedback can suppress pituitary secretion of luteinizing hormone and follicle-stimulating hormone.
This can reduce intratesticular testosterone and impair spermatogenesis.
In some men, sperm production may decline dramatically or stop.
Consequently, testosterone replacement therapy should not be assumed to improve fertility.
In fact, it can have the opposite effect.
Current AUA/ASRM guidance advises clinicians not to prescribe exogenous testosterone to men interested in current or future fertility without appropriately addressing its reproductive consequences.
Men using testosterone who wish to conceive should seek specialist evaluation.
Treatment should not be changed abruptly without medical supervision.
10. Anabolic Steroids and Fertility
Anabolic-androgenic steroid use is particularly relevant among men engaged in bodybuilding, strength training, and physique-focused activities.
Some compounds can strongly suppress the hypothalamic–pituitary–testicular axis.
This may result in reduced sperm production, testicular atrophy, and infertility.
The severity depends on the compounds used, duration, cumulative exposure, and individual physiology.
Recovery of sperm production may occur after discontinuation.
However, the timeline is variable.
Some men recover within months.
Others require substantially longer periods, and some may need specialist treatment.
The original AJOG article emphasized anabolic steroid exposure as a potentially modifiable reproductive risk.
This remains clinically important.
Men considering future parenthood should be aware that maintaining muscular appearance or high circulating androgen concentrations does not guarantee normal reproductive function.
Likewise, online protocols marketed as post-cycle therapy should not replace qualified medical evaluation.
11. Other Medications That May Influence Male Fertility
Several prescribed medications may affect reproductive function.
Examples include certain cancer therapies, hormonal treatments, and medications associated with changes in sexual function or sperm production.
However, not every medication reported to influence semen characteristics in a laboratory study produces clinically meaningful infertility.
Medication effects depend on the compound, dose, duration, underlying condition, and other factors.
A preconception review should therefore include prescription medications, over-the-counter products, supplements, and hormone-related therapies.
The objective is to identify medications requiring specialist consideration.
Patients should not independently discontinue medically necessary treatment because of concerns about fertility.
In some cases, alternative treatments are available.
In others, the health risks of stopping medication may outweigh theoretical reproductive concerns.
For individuals anticipating chemotherapy or other potentially gonadotoxic treatment, discussion of fertility preservation before treatment can be particularly important.
12. Tobacco, Nicotine, Alcohol, and Other Substance Exposures
Lifestyle-related exposures are another important component of male preconception care.
A 2024 review in Nature Reviews Urology, Influence of Substance Use on Male Reproductive Health and Offspring Outcomes, examined the evidence concerning tobacco, alcohol, cannabis, opioids, and other substances.
The authors discussed relationships among substance use, reproductive hormones, semen characteristics, and emerging findings concerning offspring health.
Tobacco smoking has been associated with impaired semen quality and oxidative injury.
Heavy alcohol consumption can disrupt reproductive hormone signaling and is associated with adverse effects on sexual and reproductive function.
Opioid exposure may suppress reproductive endocrine signaling, particularly with prolonged use.
Cannabis has also been investigated for possible effects on sperm characteristics and reproductive outcomes, although findings vary according to exposure patterns, study design, and the outcome examined.
One limitation across this literature is that people may use multiple substances simultaneously.
This can make it difficult to attribute observed outcomes to one exposure.
Nevertheless, avoiding tobacco, reducing harmful alcohol consumption, and addressing nonmedical substance use are reasonable preconception priorities.
13. Cannabis and Paternal Reproductive Health
Cannabis deserves separate consideration because its use has become increasingly common and its reproductive effects are often misunderstood.
Cannabinoids interact with biological signaling pathways, including the endocannabinoid system.
Components of this system participate in aspects of reproductive physiology.
Research has identified associations between cannabis use and certain semen or hormonal measurements.
However, human findings are inconsistent.
Differences in cannabis potency, frequency, route of administration, concurrent tobacco use, and other factors complicate interpretation.
Some observational studies have also investigated paternal cannabis use in relation to pregnancy loss or offspring outcomes.
These results do not establish that cannabis directly causes the observed conditions.
Nevertheless, prospective fathers should not assume that cannabis is reproductively harmless simply because it is legal or plant-derived.
Discussing cannabis use before conception provides an opportunity to evaluate possible risks and support informed decisions.
14. Oxidative Stress and Sperm DNA Integrity
Sperm cells are vulnerable to certain forms of oxidative damage.
Reactive oxygen species are produced during normal metabolism and participate in biological signaling.
However, excessive oxidative activity can damage cellular structures, including DNA.
Oxidative stress has therefore been proposed as one mechanism linking certain medical conditions and environmental exposures with impaired sperm function.
Potential contributors include infection, inflammation, smoking, varicocele, and other conditions.
However, oxidative stress is not a single diagnosis.
And the presence of oxidative damage does not establish that every man requires antioxidant supplementation.
The clinically important question is whether identifying or treating a specific contributor improves meaningful reproductive outcomes.
This is particularly relevant when considering sperm DNA fragmentation tests.
15. What Is Sperm DNA Fragmentation Testing?
Sperm DNA fragmentation testing evaluates certain types of DNA damage within sperm.
Several laboratory methods are available.
Elevated fragmentation has been associated with some forms of male infertility and adverse reproductive outcomes.
However, tests differ in methodology, reference values, and interpretation.
Current male infertility guidance does not recommend sperm DNA fragmentation testing as part of every initial infertility evaluation.
It may be considered in selected circumstances, such as particular cases of recurrent pregnancy loss or infertility requiring specialist investigation.
A result should be interpreted alongside semen analysis, clinical history, and other findings.
Importantly, identifying an elevated fragmentation index does not automatically establish that a commercial antioxidant protocol will improve conception or live-birth outcomes.
The evidence for treatment must be evaluated separately.
16. Male Fertility Supplements: What Did JAMA Find?
The original 2008 AJOG paper discussed early studies suggesting possible benefits from zinc and folic acid supplementation.
At the time, the evidence was limited.
In January 2020, a major randomized clinical trial published in JAMA directly tested this approach.
The investigators enrolled 2,370 couples pursuing infertility treatment.
Male participants received either a combination of 5 mg folic acid and 30 mg elemental zinc daily or placebo for six months.
The results were important.
Live birth occurred in approximately 34% of couples in the supplement group and 35% in the placebo group.
The intervention did not significantly improve most semen-quality measures.
A modest increase in measured sperm DNA fragmentation was also observed in the supplemented group.
The findings did not support routine folic acid and zinc supplementation as an infertility treatment for the population studied.
This does not mean zinc or folate are unimportant nutrients.
Both participate in essential physiological processes.
It means that giving additional amounts to men without a demonstrated deficiency did not produce the reproductive benefits that had been proposed.
17. A Newer Trial: Do Broad Antioxidant Supplements Improve Pregnancy Rates?
In September 2025, researchers published the SUMMER randomized clinical trial in JAMA Network Open.
The multicenter study investigated a combined antioxidant supplement among men seeking fertility care.
Participants were assigned to either the supplement or placebo.
The researchers evaluated ongoing pregnancy and other reproductive outcomes.
The trial found no significant improvement in ongoing pregnancy rates from the antioxidant intervention.
The authors concluded that the supplement tested should not be routinely recommended to improve reproductive outcomes in the study population.
These results reinforce an important distinction between biological plausibility and demonstrated clinical benefit.
A nutrient may participate in antioxidant defense.
A laboratory experiment may show that a compound reduces oxidative activity.
But neither finding establishes that supplementation will improve pregnancy outcomes in humans.
For preconception care, nutritional adequacy remains important.
However, routine high-dose fertility supplementation should not be presented as an established solution for unexplained male infertility.
18. Paternal Diet and the Emerging Science of Sperm Epigenetics
One of the most interesting developments in reproductive biology involves the possibility that paternal environmental exposures influence molecular information carried by sperm beyond the DNA sequence itself.
Sperm contain genetic material, but they also carry regulatory molecules, including certain RNAs.
Researchers are investigating how these molecules respond to nutrition, metabolic conditions, and other exposures.
A 2024 study published in Nature, Epigenetic Inheritance of Diet-Induced and Sperm-Borne Mitochondrial RNAs, examined these relationships.
The investigators used experimental mouse models and analyzed human observational data.
In mice, paternal dietary manipulation influenced certain sperm RNA populations and offspring metabolic characteristics.
The researchers also identified associations between paternal BMI and offspring metabolic measures in human data.
These findings suggest that paternal metabolic conditions may influence biological information associated with sperm.
However, the strongest causal evidence came from experimental animal models.
The human findings were observational.
Consequently, the study does not establish that changing a man's diet before conception will prevent obesity or metabolic disease in his children.
19. Can Paternal Obesity Influence Offspring Health?
A 2024 Nature Communications study examined whether paternal obesity could influence reproductive characteristics across generations.
The researchers investigated molecular pathways involving sperm and offspring testicular function in mice.
They identified changes in RNA regulation and other mechanisms associated with reproductive characteristics.
A smaller human component identified associations among BMI, sperm concentration, and certain molecular measurements.
These findings contribute to a developing field sometimes described as paternal epigenetic inheritance.
However, the term requires careful interpretation.
In mammals, many epigenetic marks undergo extensive reprogramming during reproduction and early development.
Demonstrating that an exposure changes sperm molecules is not the same as demonstrating that the change causes disease in human offspring.
Furthermore, results observed across mouse generations cannot automatically be generalized to human families.
This research is promising because it expands the biological questions being asked.
It does not justify commercial testing of sperm epigenetic profiles to predict a future child's health.
20. A 2026 Nature Communications Study: Sperm RNA and Metabolic Programming
In February 2026, researchers published Male Obesity Causes Adipose Mitochondrial Dysfunction in F1 Mouse Progeny via a let-7–DICER Axis in Nature Communications.
The study investigated relationships between paternal obesity, sperm microRNAs, and offspring metabolic function.
Using experimental mouse models, the researchers identified changes involving specific microRNAs and mitochondrial regulation.
They also used experimental manipulations to investigate whether those molecular signals could contribute causally to offspring phenotypes.
A human component found that weight loss among men with obesity was associated with changes in related sperm RNA measurements.
This is an important mechanistic advance.
However, the evidence that a particular human paternal intervention improves offspring health through this pathway remains unestablished.
The results should therefore be interpreted as emerging developmental biology rather than a validated clinical protocol.
For prospective parents, the most appropriate practical message remains supporting general metabolic health through established interventions.
21. Paternal Age: What Changes as Men Get Older?
Men can remain fertile later in life than women typically can.
However, male reproductive aging is not biologically irrelevant.
Sperm characteristics may change with age.
Certain genetic variants arise during sperm production and can accumulate through repeated germ-cell divisions.
Paternal age has been associated with increased frequency of some de novo genetic variants.
Certain rare genetic disorders demonstrate clear associations with advanced paternal age.
Researchers have also investigated associations with neurodevelopmental and psychiatric outcomes among offspring.
However, many such findings come from observational studies.
Their interpretation can be complicated by genetic, social, and other factors.
Absolute risks for most individual outcomes remain low.
There is also no universally accepted paternal-age threshold at which conception becomes unsafe.
The appropriate approach is individualized counseling rather than presenting age as a deterministic predictor.
22. Male Reproductive Genetics and Family History
Some causes of male infertility are genetic.
Examples include certain chromosomal abnormalities, Y-chromosome microdeletions, and genetic variants associated with abnormalities of reproductive tract development.
Klinefelter syndrome is one example of a chromosomal condition that can affect testicular development and sperm production.
Certain CFTR-related conditions may involve congenital absence of the vas deferens, which can prevent sperm from entering the ejaculate.
These conditions require specialist evaluation.
Appropriate genetic testing depends on clinical findings.
A man with azoospermia or severe oligospermia may require investigations that would not be indicated in a man with normal reproductive function.
Genetic counseling is important when testing identifies an inherited condition that may affect offspring.
Both prospective parents should also consider reproductive carrier screening according to applicable professional guidelines.
However, a consumer genomic report is not a substitute for specialized reproductive genetic evaluation.
23. Environmental and Occupational Exposures
The original AJOG paper emphasized occupational and environmental exposures as potentially important contributors to male reproductive health.
These concerns remain relevant.
Some men encounter metals, solvents, pesticides, industrial chemicals, or other substances through work or hobbies.
Lead is an established reproductive toxicant.
Other exposures have been associated with changes in semen characteristics, but the strength of evidence varies substantially.
Certain occupations may involve heat exposure or other physical conditions relevant to testicular function.
However, occupational risk cannot be determined from a job title alone.
The important variables include the particular substance, concentration, route, frequency, duration, and protective measures used.
When meaningful exposure is suspected, occupational medicine evaluation may be appropriate.
The objective is not to test every man for an extensive collection of environmental chemicals.
It is to identify specific hazards and reduce exposures where evidence supports doing so.
24. Testicular Temperature and Reproductive Function
Normal sperm production depends partly on the temperature-regulated environment of the testes.
Testicular temperature is generally lower than core body temperature.
Certain forms of prolonged heat exposure have therefore been investigated for possible effects on semen characteristics.
Potential examples include occupational heat, repeated exposure to high-temperature environments, and medical conditions associated with increased testicular temperature.
However, evidence concerning everyday activities such as laptop use, particular clothing styles, or occasional sauna exposure remains less definitive.
The biological plausibility of heat-related effects does not mean every exposure produces clinically significant infertility.
Men with documented infertility may benefit from discussing substantial or recurrent heat exposures with a reproductive specialist.
However, excessive restriction of ordinary activities without an established medical indication is not necessary.
25. Exercise and Physical Fitness
Physical activity is an important component of general health.
Regular exercise supports cardiovascular fitness, metabolic regulation, musculoskeletal function, and psychological well-being.
These benefits are relevant to prospective fathers.
Exercise may also contribute to improved body composition and metabolic health in men with obesity.
However, the relationship between exercise and semen quality is complex.
Training volume, intensity, recovery, nutritional adequacy, and underlying health conditions may influence reproductive physiology.
Extremely high training loads combined with inadequate energy intake can alter endocrine function.
Similarly, performance-enhancing drugs may introduce reproductive risks independent of exercise itself.
The objective is not to prescribe one universal exercise program for improving fertility.
It is to support an appropriate, sustainable level of physical activity consistent with the individual's health and goals.
For most men, established physical activity recommendations provide a reasonable foundation.
26. Psychological Stress, Sleep, and Male Reproductive Health
Stress and sleep may influence reproductive health through several pathways.
The hypothalamic–pituitary–testicular axis interacts with broader neuroendocrine systems.
Sleep participates in hormonal regulation and recovery.
Psychological stress may influence sexual function, behavior, and physiological responses.
However, the evidence linking ordinary stress directly to infertility remains inconsistent.
The original AJOG paper acknowledged this uncertainty.
Some studies found associations between stress and semen characteristics.
Others found no meaningful relationship.
That distinction remains relevant.
Men should not be told that infertility results from insufficient relaxation or poor stress management.
Nevertheless, persistent sleep disturbance, depression, anxiety, and other psychological concerns deserve appropriate care.
Improving psychological well-being has value independently of whether it changes semen parameters.
For individuals experiencing sexual dysfunction or fertility-related distress, medical and psychological support may be especially useful.
27. Paternal Mental Health and Preparation for Fatherhood
Preconception healthcare should not end with reproductive biology.
Men may experience psychological changes related to family planning, fertility treatment, financial responsibilities, and expectations surrounding parenthood.
Depression and anxiety can occur before and after childbirth.
The original AJOG paper emphasized that paternal mental health may influence family relationships, caregiving, and child well-being.
This remains an important consideration.
Supportive fatherhood involves more than biological contribution.
It includes communication, emotional availability, shared responsibility, and participation in caregiving.
A prospective father may benefit from discussing expectations with his partner, evaluating his support network, and addressing psychological concerns before they become more disruptive.
However, mental health should not be assessed solely according to its possible effects on a partner or child.
Men deserve appropriate psychological healthcare for their own well-being.
28. Reproductive Planning Should Be Shared
A reproductive life plan describes an individual's goals concerning whether and when to have children.
It can include family size preferences, contraception, fertility considerations, and the timing of conception.
The original AJOG paper argued that men should participate actively in these discussions rather than assume that responsibility belongs primarily to women.
This remains relevant.
Both partners contribute to decisions concerning pregnancy timing.
They may also need to coordinate medical appointments, financial planning, lifestyle changes, or fertility treatment.
However, shared planning must respect reproductive autonomy.
Neither partner should exercise coercive control over the other's healthcare decisions.
A healthy preconception process encourages communication and mutual understanding while preserving individual consent.
29. What Should a Comprehensive Male Preconception Assessment Include?
An evidence-informed assessment can consider several major domains.
Reproductive history: Previous pregnancies, infertility, testicular conditions, sexual function, and known reproductive diagnoses.
Medical history: Diabetes, obesity, endocrine disorders, chronic illness, previous surgery, and relevant infections.
Medication review: Testosterone, anabolic steroids, prescription medications, supplements, and prior gonadotoxic treatments.
Family history: Known inherited conditions and genetic circumstances that may affect reproductive risk.
Metabolic health: Blood pressure, body composition, relevant glucose and lipid measurements, and other indicators when clinically appropriate.
Lifestyle behaviors: Tobacco, alcohol, cannabis, physical activity, nutrition, and sleep.
Environmental exposures: Occupational chemicals, metals, solvents, pesticides, and relevant heat exposures.
Psychological and social well-being: Stress, mental health, relationships, and preparation for parenthood.
Sexual and infectious health: Appropriate STI screening, vaccination history, and related concerns.
Fertility testing: Semen analysis, hormonal measurements, or specialist testing when indicated.
Not every man requires every test. The objective is to identify relevant risks and choose assessments capable of informing meaningful decisions.
30. How Far in Advance Should Men Prepare?
Because sperm production takes approximately two to three months, preconception planning is often discussed within a similar timeframe.
This can be useful when developing a realistic plan for lifestyle changes or addressing identified reproductive concerns.
However, a 90-day period should not be interpreted as a scientifically established guarantee of sperm regeneration or improved offspring health.
Some changes may occur more quickly.
Others may require longer periods.
Recovery from testosterone-induced suppression or certain medical treatments may take many months or longer.
Furthermore, the absence of symptoms does not establish that sperm production is normal.
Men with known reproductive concerns should seek appropriate evaluation rather than relying exclusively on a fixed preparation period.
For otherwise healthy men, beginning general health optimization several months before attempting conception is a reasonable practical strategy.
31. Practical Steps for Prospective Fathers
A useful preconception plan should prioritize actions with established health benefits and appropriate clinical relevance.
Establish a reproductive life plan. Discuss pregnancy timing, family goals, and relevant concerns with your partner.
Review medical conditions. Address diabetes, obesity, hypertension, endocrine disorders, and other relevant health concerns with a qualified clinician.
Discuss testosterone and anabolic steroid use. These can suppress sperm production and may require specialist management.
Address tobacco and harmful substance exposure. Seek evidence-based support for cessation or treatment where appropriate.
Support metabolic health. Maintain appropriate physical activity, adequate nutrition, and a sustainable approach to weight management.
Review medications and supplements. Avoid assuming that over-the-counter fertility products are effective or harmless.
Consider occupational exposures. Identify meaningful exposure to reproductive toxicants and pursue appropriate workplace protections.
Review sexual and genetic health. Obtain relevant infection screening and genetic counseling when indicated.
Address psychological well-being. Seek support for persistent distress, sleep problems, or mental health concerns.
Obtain fertility evaluation when appropriate. Do not delay assessment when there are established indications or known risk factors.
These actions support reproductive readiness while also promoting long-term men's health.
32. How This Research Informs Our Preconception Care
We recognize that conscious conception should involve both prospective parents.
Men's reproductive health exists within a broader physiological context involving endocrine regulation, metabolic function, nutrition, movement, environmental exposures, and psychological well-being.
Our HIM men's health and preconception services emphasize research-informed education and personalized assessment of relevant lifestyle and health-related factors.
For example, an individual may benefit from evaluating metabolic health, nutritional habits, physical activity, sleep, or tobacco use before attempting conception.
Another may require review of testosterone therapy or referral to a reproductive urologist.
Someone with a history of infertility may need formal semen analysis, specialist evaluation, or reproductive genetic counseling.
We also recognize that the rapidly developing field of sperm epigenetics raises important scientific questions.
However, emerging findings should not be used to promise that lifestyle interventions can prevent genetic disorders or determine a child's future metabolic health.
Similarly, supplementation protocols should not be presented as effective fertility treatments merely because their ingredients participate in reproductive biology.
Our objective is to help prospective fathers identify meaningful opportunities for prevention, understand appropriate screening, and participate actively in reproductive planning.
When specialized fertility evaluation, endocrine management, addiction treatment, or medical treatment is required, collaboration with qualified clinicians is essential.
A father's health deserves attention not only because of what he contributes to conception, but also because of the health, capacity, and well-being he brings to parenthood.
Conclusion: Healthy Conception Is a Shared Biological Responsibility
For much of modern healthcare history, preconception planning has focused primarily on women.
The original 2008 AJOG paper challenged this imbalance.
It argued that men should be recognized as active participants in reproductive health and that preconception care could improve both fertility-related outcomes and men's general health.
Contemporary research has strengthened this perspective.
Metabolic health is associated with semen quality.
Certain medications and hormone therapies can substantially alter sperm production.
Tobacco, alcohol, and other exposures may influence reproductive physiology.
Genetic conditions can contribute to infertility.
And emerging research suggests that sperm carry molecular information that may respond to paternal environmental conditions.
However, important scientific boundaries remain.
Improving a semen parameter does not guarantee pregnancy.
An epigenetic change does not establish a future developmental disorder.
A supplement that influences antioxidant pathways does not necessarily improve live-birth rates.
And no single lifestyle strategy can eliminate all reproductive risks.
The most effective preconception approach combines appropriate medical evaluation, meaningful lifestyle changes, informed reproductive planning, and evidence-based interventions.
For men, this represents an opportunity to take a more active role in their own health and in preparation for parenthood.
Preparing for a healthy pregnancy is not exclusively about optimizing the maternal environment. It is also about recognizing the biological and personal contributions of the prospective father—and supporting the health of both individuals before conception begins.
Research References
Frey KA, Navarro SM, Kotelchuck M, Lu MC. The clinical content of preconception care: preconception care for men. American Journal of Obstetrics and Gynecology. 2008;199(6 Suppl 2)–S395. https://doi.org/10.1016/j.ajog.2008.10.024
Santoro N, Polotsky AJ. Infertility evaluation and treatment. New England Journal of Medicine. 2025;392:1111–1119. https://doi.org/10.1056/NEJMcp2311150
Boxem AJ, Blaauwendraad SM, Mulders AGMGJ, et al. Preconception and early-pregnancy body mass index in women and men, time to pregnancy, and risk of miscarriage. JAMA Network Open. 2024;7. https://doi.org/10.1001/jamanetworkopen.2024.36157
Association between body mass index and semen quality: a systematic review and meta-analysis. International Journal of Obesity. 2024;48:1383–1401. https://doi.org/10.1038/s41366-024-01580-w
Andersen E, Juhl CR, Kjøller ET, et al. Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial. Human Reproduction. 2022;37:1414–1422. https://doi.org/10.1093/humrep/deac096
Schisterman EF, Sjaarda LA, Clemons T, et al. Effect of folic acid and zinc supplementation in men on semen quality and live birth among couples undergoing infertility treatment: a randomized clinical trial. JAMA. 2020;323:35–48. https://doi.org/10.1001/jama.2019.18714
de Ligny WR, de Bruin JP, Smits RM, et al. Antioxidant treatment and the chance to conceive in men seeking fertility care: the SUMMER randomized clinical trial. JAMA Network Open. 2025;8. https://doi.org/10.1001/jamanetworkopen.2025.32405
Lo JO, Hedges JC, Chou WH, et al. Influence of substance use on male reproductive health and offspring outcomes. Nature Reviews Urology. 2024;21:534–564. https://doi.org/10.1038/s41585-024-00868-w
Tomar A, et al. Epigenetic inheritance of diet-induced and sperm-borne mitochondrial RNAs. Nature. 2024. https://doi.org/10.1038/s41586-024-07472-3
Xiong YW, Zhu HL, Zhang J, et al. Multigenerational paternal obesity enhances the susceptibility to male subfertility in offspring via Wt1 N6-methyladenosine modification. Nature Communications. 2024;15:1353. https://doi.org/10.1038/s41467-024-45675-4
Huang C, et al. Male obesity causes adipose mitochondrial dysfunction in F1 mouse progeny via a let-7–DICER axis. Nature Communications. 2026;17:3125. https://doi.org/10.1038/s41467-026-69686-5
Pecorelli S, Lucchini R, Lambertini L, et al. Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health. Nature Reviews Urology. 2026;23:556–557. https://doi.org/10.1038/s41585-026-01128-9
American Urological Association and American Society for Reproductive Medicine. Diagnosis and treatment of infertility in men: AUA/ASRM guideline. 2020; amended 2024. https://www.auanet.org/guidelines-and-quality/guidelines/male-infertility
European Association of Urology. Sexual and reproductive health guidelines: male infertility. https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-infertility